About Progress Pharma
Progress Pharma is a public limited company (NV/SA) based in Vosselaar, founded in 2013. Its main activity is classified as "Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied". For the 2025 financial year, Progress Pharma reported a loss of €5,479. That makes 10 loss-making financial years in a row for Progress Pharma. Revenue was not published, which is common for abbreviated accounts. The gross margin came to -€4,893. Equity stands at €47,137, a solvency ratio of 94%. In 2014 it was €254,709. 12 annual accounts are available, covering 2014 to 2025.
- Signals
-
Reporting lossesReporting losses € -5K
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -5KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -5KEBITDA is negative: operating activities are loss-making.
Low riskLow risk 94.4%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 6.47A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
- Directors
- Concorde Consulting Bv, R&S Consulting Bv, Salvegen Healthcare Bv, +2 more
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
-5K
|
€
-2K
|
€
-1K
|
€
-941
|
|
|
€
-5K
|
€
-3K
|
€
-2K
|
€
-1K
|
|
|
€
-5K
|
€
-3K
|
€
-2K
|
€
-1K
|
|
|
€
47K
|
€
93K
|
€
96K
|
€
97K
|
|
|
94.4%
|
98.48%
|
98.85%
|
99.45%
|
|
|
€
3K
|
€
1K
|
€
1K
|
€
536
|
|
|
€
18K
|
€
62K
|
€
65K
|
€
66K
|
Publications 7
All publications- Ontslagen - Benoemingen 10/10/2024
- Kapitaal - Aandelen - Ontslagen - Benoemingen - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 06/04/2020
- Ontslagen - Benoemingen 15/12/2016
- Me. - Jaarrekening 31.12.2015, Ggk 23.05.2016, Ngl 17.06.2016 16195-0426-013 23/06/2016
- Me. - Jaarrekening 31.12.2014, Ggk 15.05.2015, Ngl 17.06.2015 15195-0477-013 24/06/2015
Frequently asked questions
Answers to the most common questions about Progress Pharma, based on official government data and the filed annual accounts.
What is the VAT number of Progress Pharma?
The VAT number of Progress Pharma is BE0536.258.560.
When was Progress Pharma established?
Progress Pharma was founded in 27-06-2013.
What is the official address of Progress Pharma?
The official address of Progress Pharma is Roekendreef 14 Vosselaar 2350.
What is the legal form of Progress Pharma?
The juridical form of Progress Pharma is Public limited company (NV/SA).
What is the annual revenue of Progress Pharma?
The 2025 accounts of Progress Pharma do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Progress Pharma a reliable company?
Progress Pharma is a registered Rechtspersoon with company number 0536.258.560 and can be verified through the official CBE database.
What is the credit limit of Progress Pharma?
The estimated credit limit of Progress Pharma is €2,298.
Is Progress Pharma still active?
Progress Pharma currently has the status "Normal situation" and is active.